Merck (MRK) to Acquire cCAM Biotherapeutics in ~$605M Deal

July 28, 2015 7:58 AM

Merck (NYSE: MRK) and cCAM Biotherapeutics announced that the companies have signed a definitive agreement under which Merck will acquire ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found